title: The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates.
authors.affiliation: Imperial Cancer Research Fund, Paediatric and Neuro-Oncology Group, Frenchay Hospital, Bristol, UK.
authors.forename: K
authors.initials: K
authors.lastname: Hopkins
authors.forename: V
authors.initials: V
authors.lastname: Papanastassiou
authors.forename: J T
authors.initials: JT
authors.lastname: Kemshead
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000532:radiotherapy*; D004307:Dose-Response Relationship, Radiation; D005910:Glioma / Q000532:radiotherapy*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage / Q000627:therapeutic use*; D015552:Injections, Intralesional; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D008657:Metabolic Clearance Rate; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D016499:Radioimmunotherapy; D011879:Radiotherapy Dosage; D012062:Relative Biological Effectiveness; D015996:Survival Rate; D015021:Yttrium Radioisotopes / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D018796:Immunoconjugates; D007457:Iodine Radioisotopes; D015021:Yttrium Radioisotopes